Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
8.16 -0.17 (-2.04%) 11:37 ET [NASDAQ]
8.15 x 20 8.19 x 100
Realtime by (Cboe BZX)
8.15 x 20 8.19 x 100
Realtime 6.46 -1.87 (-22.45%) 05:47 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.57
Day High
8.37
Open 7.79
Previous Close 8.33 8.33
Volume 143,964 143,964
Avg Vol 403,295 403,295
Stochastic %K 20.08% 20.08%
Weighted Alpha +30.23 +30.23
5-Day Change -0.85 (-8.96%) -0.85 (-8.96%)
52-Week Range 3.90 - 14.38 3.90 - 14.38
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 682,594
  • Shares Outstanding, K 81,944
  • Annual Sales, $ 573,280 K
  • Annual Income, $ -33,540 K
  • EBIT $ 32 M
  • EBITDA $ 82 M
  • 60-Month Beta 0.92
  • Price/Sales 1.31
  • Price/Cash Flow 8.55
  • Price/Book 4.02

Options Overview Details

View History
  • Implied Volatility 130.16% ( -10.68%)
  • Historical Volatility 81.69%
  • IV Percentile 93%
  • IV Rank 58.93%
  • IV High 195.98% on 07/19/24
  • IV Low 35.70% on 05/21/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 82
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 1,584
  • Open Int (30-Day) 1,539

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.72 +7.90%
on 04/07/25
Period Open: 9.20
11.25 -25.96%
on 03/11/25
-0.90 (-9.46%)
since 03/07/25
3-Month
7.72 +7.90%
on 04/07/25
Period Open: 9.55
11.25 -25.96%
on 03/11/25
-1.25 (-12.77%)
since 01/07/25
52-Week
3.90 +113.59%
on 04/30/24
Period Open: 5.06
14.38 -42.07%
on 11/04/24
+3.24 (+64.62%)
since 04/05/24

Most Recent Stories

More News
Ensign Group Invests in Growth With New Facility Acquisitions

The Ensign Group, Inc. ENSG recently announced a series of strategic acquisitions across Washington and California. These acquisitions, effective April 1, 2025, underscore the company’s commitment to...

OPCH : 32.56 (-2.92%)
ADMA : 18.21 (+1.11%)
ENSG : 125.20 (-3.19%)
BVS : 8.16 (-2.04%)
Bioventus: Q4 Earnings Snapshot

Bioventus: Q4 Earnings Snapshot

BVS : 8.16 (-2.04%)
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

BVS : 8.16 (-2.04%)
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

BVS : 8.16 (-2.04%)
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BVS : 8.16 (-2.04%)
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

BVS : 8.16 (-2.04%)
Bioventus: Q3 Earnings Snapshot

Bioventus: Q3 Earnings Snapshot

BVS : 8.16 (-2.04%)
Bioventus Reports Third Quarter Financial Results

BVS : 8.16 (-2.04%)
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

BVS : 8.16 (-2.04%)
Here's Why Investors Should Consider Buying Corcept Stock Now

Corcept Therapeutics’ CORT sole-marketed drug, Korlym (mifepristone), which is approved for treating Cushing's syndrome, has been performing well. The drug has been witnessing strong demand in the past...

CORT : 72.60 (-2.48%)
KRYS : 161.64 (-5.64%)
ANIP : 65.94 (-2.34%)
BVS : 8.16 (-2.04%)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 9.54
2nd Resistance Point 9.23
1st Resistance Point 8.78
Last Price 8.16
1st Support Level 8.02
2nd Support Level 7.71
3rd Support Level 7.26

See More

52-Week High 14.38
Fibonacci 61.8% 10.38
Fibonacci 50% 9.14
Last Price 8.16
Fibonacci 38.2% 7.90
52-Week Low 3.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades